China's domestic demand engine is clearly sputtering — retail sales undershot and the investment slump deepened, so the consumer part of the Chinese market has no fundamental support right now. That weakness lands at the worst possible moment: Asian share

Verdict: China demand case is real, but the rule book isn't built for this short — wait

The macro leg of this short is genuinely supported: per CNBC's September 15, 2026 report, August retail sales missed and the investment slump deepened, and Alibaba's fiscal year ended March 31, 2026 shows operating margin collapsing from 14.1% to 4.9% while operating cash flow was halved to $11.0B. Ownership and payout signals lean the same way — institutional filings for the period ended June 30, 2026 (the deadline has passed, so this is the most recent cycle) show net open-market selling of roughly $70.8M, and the dividend fell from $2.00 to $1.05 per share on the June 11, 2026 ex-date, a 47.5% annual decline. But the fundamentals cut both ways: revenue still grew 8.1% to $148.4B, gross margin held essentially flat at 39.8%, and net income of $15.0B is a weaker year, not a broken business — hard to square with a demand collapse thesis. The strongest argument against is execution: the published rule set fires long entries on weakness, only the 9-month window traded (4 trades, 75% win rate, +5.4% return, 1.8% drawdown on coarse daily-bar fills), the 12-, 24-, and 60-month windows failed on incomplete FXI data, and no robust parameter setup was established. The setup is close to live — BABA at $109.23 sits below its $117.36 50-day EMA with RSI at 27.6, and only the MACD cross at -3.12 awaits confirmation — so the verdict is wait, not act.

Trade now: the entry is one crossover away

This setup is close to live. On the daily chart, BABA last traded at $109.23, well below its 50-day EMA of $117.36 — that entry condition is met. The RSI (14) is 27.6, comfortably under the 45 threshold — met. ADX (14) at 59.0 is far above the 20 floor, confirming a strong trend — met. The one condition not fully triggered is the MACD (12,26,9) crossing below its signal line: the reading sits at -3.12, right at the level, so it is flagged near rather than confirmed. Practically, "wait" means one to two daily closes confirming that MACD cross before the entry fires. The same conditions are essentially mirrored on FXI at $34.84 (RSI 43.9, ADX 22.1, price just under its EMA of $35.35), while XLP is the laggard: its RSI is 48.8, still 3.8 points above the 45 ceiling, so the US consumer leg is not in range. Risk is defined mechanically. A hard stop closes any position at a 5.0% loss, and the take-profit level is a 10.0% gain — an effective 2:1 reward-to-risk. Positions are capped at 25% of capital with fixed-risk sizing of about 2.44% per trade. There is also a support-break exit: for BABA, a close at or below the nearest support level at $111.66 would end the trade early. The evidence behind acting on this trigger is a completed 9-month backtest on the BABA pair: 4 trades, a 75% win rate, a 5.4% total return, and a maximum drawdown of just 1.8%. One caveat on exit quality: fills were modeled on daily bars rather than intrabar prices, so treat the drawdown figure as coarse. No robust alternative parameter setup was established, so trade the published rules as written.

The demand-collapse short runs into a company still growing revenue at 8%

The bull case against this short starts with Alibaba's top line. Revenue grew 8.1% year over year to $148.4B for the fiscal year ended March 31, 2026, and gross margin held essentially flat at 39.8% versus 40.0% the prior year. A demand collapse severe enough to justify shorting a broad Chinese large-cap vehicle should show up in the largest Chinese consumer platform's revenue — it has not. Alibaba also ranks in the 70th percentile of its sector on return on equity (9.8%) and the 64th percentile on operating margin among 854 Information Technology peers, hardly the profile of a business starved of customers. The balance sheet provides another cushion: $19.1B in cash against $113.6B in total liabilities and $153.8B in equity, with a current ratio of 1.28. The company also continued shrinking its share count — reported shares outstanding fell from roughly 18.5 billion to 1.86 billion year over year — an aggressive capital-return posture that mechanically supports per-share value even in a soft demand environment. The backtest itself cuts against the idea's direction. The completed 9-month window is a long-biased rule set (entries trigger when price sits below the 50-day EMA with RSI under 45), and it produced 4 trades, a 75% win rate, a +5.4% return, and only a 1.8% maximum drawdown — meaning weakness in these names has historically been shallow…

Scores

• Conviction score breakdown: 48
• Thesis support: 60
• Trade readiness: 55
• Risk quality: 50
• Backtest evidence: 35
• Fundamentals trend: 40

Watch items

• BABA — MACD (12,26,9) cross below signal
• BABA — Price vs 50-day EMA
• BABA — RSI (14)
• BABA — Close vs nearest support
• FXI — Price vs 50-day EMA
• FXI — RSI (14)
• XLP — RSI (14)
• BABA — Insider/institutional net open-market flow